Background: We evaluated a new in vitro model for mucociliary transport function. Spheroids of human respiratory epithelium show beating cilia at their surface. When cultured in their own mucus, spheroids can rotate along their axis due to coordinated ciliary beating. Objective and Methods: To assess whether this setup yields meaningful results we measured rotation frequency (RF) of human bronchial or nasal epithelial spheroids under different temperatures and concentrations of isoproterenol. Isoproterenol was administered either as caged compound releasing active isoproterenol after illumination with UV light, or through a permeable membrane in a two-chamber system. Results: Under stable conditions, RF remained constant over 200 min. Between 27 and 35°C, there was a temperature-dependent increase: RF27°C = 0.27 ± 0.08 s–1, and RF37°C = 0.43 ± 0.10 s–1 (means ± SEM). Isoproterenol (10–5, 10–4 and 10–3 mmol/l) induced concentration-dependent increases in RF (9, 20 and 25%, respectively; medians) if applied in the two-chamber system. The experiments with caged isoproterenol did not yield conclusive results, probably because the byproducts from photolysis negatively affected ciliary function. The transport velocity at the surface of bronchial and nasal spheroids was estimated to be 2.96 and 3.62 mm/min (medians), respectively, which is in the same range as mucus transport velocity measured in vivo in humans. Conclusions: This setup can be used to study mucociliary transport function under controlled conditions in vitro, in particular as RF is likely to reflect not only ciliary beat frequency, but also the coordination of ciliary beating and the properties of the mucus.

Keywords:
Functional assay, Isoproterenol, Mucociliary function, Mucus transport velocity, Rotation, Spheroids
1.
Jorissen M: Correlations among mucociliary transport, ciliary function, and ciliary structure. Am J Rhinol 1998;12:53–58.
2.
Corssen G, Allen CR: Acetylcholine: its significance in controlling ciliary activity of human respiratory epithelium in vitro. J Appl Physiol 1959;14:901–904.
3.
Jorissen M, Van der SB, Tyberghein J, Van der BH, Cassiman JJ: Ciliogenesis and coordinated ciliary beating in human nasal epithelial cells cultured in vitro. Acta Otorhinolaryngol Belg 1989;43:67–73.
4.
Sanderson MJ, Dirksen ER: Mechanosensitivity of cultured ciliated cells from the mammalian respiratory tract: implications for the regulation of mucociliary transport. Proc Natl Acad Sci USA 1986;83:7302–7306.
5.
Al Batran SE, Astner ST, Supthut M, Gamarra F, Brueckner K, Welsch U, Knuechel R, Huber RM: Three-dimensional in vitro cocultivation of lung carcinoma cells with human bronchial organ culture as a model for bronchial carcinoma. Am J Respir Cell Mol Biol 1999;21:200–208.
6.
Gamarra F, Wagner S, Al Batran S, Maier I, Castro M, Hautmann H, Bergner A, Baumgartner R, Huber RM: Kinetics of 5-aminolevulinic acid-induced fluorescence in organ cultures of bronchial epithelium and tumor. Respiration 2002;69:445–450.
7.
Adams SR, Tsien RY: Controlling cell chemistry with caged compounds. Annu Rev Physiol 1993;55:755–784.
8.
Bridges MA, Walker DC, Harris RA, Wilson BR, Davidson AG: Cultured human nasal epithelial multicellular spheroids: polar cyst-like model tissues. Biochem Cell Biol 1991;69:102–108.
9.
Armengot M, Basterra J, Garcia-Bartual E: The influence of anesthetics and vasoconstrictors on nasal mucociliary transport. Acta Otorhinolaryngol Belg 1989;43:149–156.
10.
Morgan L, Pearson M, de Iongh R, Mackey D, van der Wall H, Peters M, Rutland J: Scintigraphic measurement of tracheal mucus velocity in vivo. Eur Respir J 2004;23:518–522.
11.
Wanner A, Salathe M, O’Riordan TG: Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996;154:1868–1902.
12.
Jorissen M, Bessems A: Influence of culture duration and ciliogenesis on the relationship between ciliary beat frequency and temperature in nasal epithelial cells. Eur Arch Otorhinolaryngol 1995;252:451–454.
13.
Kurosawa H, Wang CG, Dandurand RJ, King M, Eidelman DH: Mucociliary function in the mouse measured in explanted lung tissue. J Appl Physiol 1995;79:41–46.
14.
Mercke U, Hakansson CH, Toremalm NG: The influence of temperature on mucociliary activity. Temperature range 20 degrees C-40 degrees C. Acta Otolaryngol 1974;78:444–450.
15.
Mercke U: The influence of temperature on mucociliary activity. Temperature range 40 degrees C to 50 degrees C. Acta Otolaryngol 1974;78:253–258.
16.
Kilgour E, Rankin N, Ryan S, Pack R: Mucociliary function deteriorates in the clinical range of inspired air temperature and humidity. Intensive Care Med 2004;30:1491–1494.
17.
Agu RU, Jorissen M, Willems T, Van den Mooter G, Kinget R, Augustijns P: Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: a comparative study of cell culture models. Pharm Res 1999;16:1380–1385.
18.
Wyatt TA, Spurzem JR, May K, Sisson JH: Regulation of ciliary beat frequency by both PKA and PKG in bovine airway epithelial cells. Am J Physiol 1998;275:L827–L835.
19.
Sanderson MJ, Dirksen ER: Mechanosensitive and beta-adrenergic control of the ciliary beat frequency of mammalian respiratory tract cells in culture. Am Rev Respir Dis 1989;139:432–440.
20.
Muralidharan S, Nerbonne JM: Photolabile ‘caged’ adrenergic receptor agonists and related model compounds. J Photochem Photobiol B 1995;27:123–137.
21.
Muralidharan S, Maher GM, Boyle WA, Nerbonne JM: ‘Caged’ phenylephrine: development and application to probe the mechanism of alpha-receptor-mediated vasoconstriction. Proc Natl Acad Sci USA 1993;90:5199–5203.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.